MNDR Fundamental Analysis - MOBILE-HEALTH NETWORK SOLUTI

Name: MOBILE-HEALTH NETWORK SOLUTI (MNDR) Stock
Brand: MOBILE-HEALTH NETWORK SOLUTI
Rating: 5.5 (3 reviews)

Fundamental Rating

Overall MNDR gets a fundamental rating of 3 out of 10. We evaluated MNDR against 101 industry peers in the Health Care Providers & Services industry. MNDR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MNDR is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year MNDR has reported negative net income.

1.2 Ratios

Looking at the Return On Assets, with a value of -401.37%, MNDR is doing worse than 97.03% of the companies in the same industry.

MNDR has a worse Return On Equity (-678.46%) than 82.18% of its industry peers.

		Industry Rank	Sector Rank
ROA	-401.37%
ROE	-678.46%
ROIC	N/A

ROA(3y)-96.24%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MNDR has a Gross Margin of 17.39%. This is in the lower half of the industry: MNDR underperforms 64.36% of its industry peers.

In the last couple of years the Gross Margin of MNDR has declined.

MNDR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	17.39%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-5.09%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MNDR does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for MNDR has been increased compared to 1 year ago.

MNDR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -16.22, we must say that MNDR is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of -16.22, MNDR is not doing good in the industry: 92.08% of the companies in the same industry are doing better.

There is no outstanding debt for MNDR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-16.22

ROIC/WACCN/A

WACC9.23%

2.3 Liquidity

MNDR has a Current Ratio of 2.04. This indicates that MNDR is financially healthy and has no problem in meeting its short term obligations.

MNDR has a better Current ratio (2.04) than 75.25% of its industry peers.

A Quick Ratio of 1.96 indicates that MNDR should not have too much problems paying its short term obligations.

Looking at the Quick ratio, with a value of 1.96, MNDR is in the better half of the industry, outperforming 75.25% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.04
Quick Ratio	1.96

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for MNDR have decreased strongly by -342.98% in the last year.

Looking at the last year, MNDR shows a very strong growth in Revenue. The Revenue has grown by 25.66%.

Measured over the past years, MNDR shows a very strong growth in Revenue. The Revenue has been growing by 75.52% on average per year.

EPS 1Y (TTM)-342.98%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-11.69%

Revenue 1Y (TTM)25.66%

Revenue growth 3Y75.52%

Revenue growth 5YN/A

Sales Q2Q%-35.64%

3.2 Future

MNDR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.56% yearly.

Based on estimates for the next years, MNDR will show a very strong growth in Revenue. The Revenue will grow by 78.77% on average per year.

EPS Next Y99.23%

EPS Next 2Y41.56%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year81.13%

Revenue Next 2Y78.77%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MNDR. In the last year negative earnings were reported.

MNDR is valuated quite expensively with a Price/Forward Earnings ratio of 128.43.

Compared to the rest of the industry, the Price/Forward Earnings ratio of MNDR indicates a slightly more expensive valuation: MNDR is more expensive than 62.38% of the companies listed in the same industry.

Compared to an average S&P500 Price/Forward Earnings ratio of 22.50, MNDR is valued quite expensively.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	128.43

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

MNDR's earnings are expected to grow with 41.56% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y41.56%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MNDR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MOBILE-HEALTH NETWORK SOLUTI

NASDAQ:MNDR (10/30/2025, 8:26:11 PM)

After market: 2.6 -0.02 (-0.76%)

2.62

-0.09 (-3.5%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)10-23 2024-10-23

Earnings (Next)N/A N/A

Inst Owners2.51%

Inst Owner Change-7.14%

Ins Owners18.09%

Ins Owner ChangeN/A

Market Cap3.22M

Revenue(TTM)18.24M

Net Income(TTM)-17258700

Analysts82.86

Price TargetN/A

Short Float %N/A

Short Ratio0.23

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	128.43
P/S	0.18
P/FCF	N/A
P/OCF	N/A
P/B	1.27
P/tB	1.86
EV/EBITDA	N/A

EPS(TTM)-4.87

EYN/A

EPS(NY)0.02

Fwd EY0.78%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS14.83

BVpS2.07

TBVpS1.41

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-401.37%
ROE	-678.46%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	17.39%
FCFM	N/A

ROA(3y)-96.24%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-5.09%

GM growth 5YN/A

F-ScoreN/A

Asset Turnover4.24

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.04
Quick Ratio	1.96
Altman-Z	-16.22

F-ScoreN/A

WACC9.23%

ROIC/WACCN/A

Cap/Depr(3y)101.22%

Cap/Depr(5y)N/A

Cap/Sales(3y)1.18%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-342.98%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-11.69%

EPS Next Y99.23%

EPS Next 2Y41.56%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)25.66%

Revenue growth 3Y75.52%

Revenue growth 5YN/A

Sales Q2Q%-35.64%

Revenue Next Year81.13%

Revenue Next 2Y78.77%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-267.22%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year69.85%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-168.61%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-184.86%

OCF growth 3YN/A

OCF growth 5YN/A

MOBILE-HEALTH NETWORK SOLUTI / MNDR FAQ

What is the ChartMill fundamental rating of MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MNDR.

What is the valuation status of MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?

ChartMill assigns a valuation rating of 1 / 10 to MOBILE-HEALTH NETWORK SOLUTI (MNDR). This can be considered as Overvalued.

How profitable is MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?

MOBILE-HEALTH NETWORK SOLUTI (MNDR) has a profitability rating of 0 / 10.

Can you provide the financial health for MNDR stock?

The financial health rating of MOBILE-HEALTH NETWORK SOLUTI (MNDR) is 6 / 10.

MOBILE-HEALTH NETWORK SOLUTI (MNDR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MOBILE-HEALTH NETWORK SOLUTI / MNDR FAQ

What is the ChartMill fundamental rating of MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?

What is the valuation status of MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?

How profitable is MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?

Can you provide the financial health for MNDR stock?